Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 86 of 3395 for:    Recruiting, Not yet recruiting, Available Studies | Pain

Intranasal Fentanyl Versus Oral Morphine Sulfate in the Treatment of Pain in Pediatric Trauma (FINDOL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03063359
Recruitment Status : Recruiting
First Posted : February 24, 2017
Last Update Posted : January 7, 2019
Sponsor:
Information provided by (Responsible Party):
University Hospital, Montpellier

Brief Summary:

Acute tramatic pain is one of main reasons for consultation in pediatric emergency departments.

To manage pain quickly and effectively must be a primary outcome of the emergency department. However, pediatric emergency department are sometimes criticized for inadequate and delayed initiation analgesia . Indeed, several studies have shown the inadequacy between the intensity of the pain evaluated by the care team and the therapeutic management of it.

The ideal analgesic must have a rapid onset of action, have a powerful analgesic effect, have few side effects and can be administered quickly and painlessly. That's why, the main outcome of this study is to assess the non inferiority of a treatment by intranasal Fentanyl vs morphine sulfate (oral use) in children with traumatic pain on arrival to pediatric emergency department.


Condition or disease Intervention/treatment Phase
Pain, Acute Drug: Intranasal fentanyl + Oral Placebo Drug: Oral Morphine + Intranasal Placebo Phase 3

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 82 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Non-inferiority of Intranasal Fentanyl Versus Oral Morphine Sulfate in the Treatment of Pain in Pediatric Trauma : a Controled Randomized , Single Blind Study
Actual Study Start Date : May 30, 2017
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : May 2021

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Intranasal fentanyl + Oral placebo
Administration of intranasal fentanyl (1.5µg/kg) and oral placebo in children with acute pain in traumatic context on arrival in emergency pediatric department.
Drug: Intranasal fentanyl + Oral Placebo
Administration of intranasal fentanyl (1.5µg/kg) and Oral placebo (NaCl 0.9%) in children with acute pain in traumatic context on arrival in emergency pediatric department.
Other Name: Intranasal Fentanyl + Oral NaCl

Active Comparator: Oral morphine + Intranasal placebo
Administration of oral morphine (0.4mg/kg) and intranasal placebo in children with acute pain in traumatic context on arrival in emergency pediatric department.
Drug: Oral Morphine + Intranasal Placebo
Administration of oral morphine (0,4mg/kg) and intranasal placebo (NaCl 0.9%) in children with acute pain in traumatic context on arrival in emergency pediatric department.
Other Name: Oral Morphine + Intranasal NaCl




Primary Outcome Measures :
  1. Assessment of the value of the pain feeling [ Time Frame: 45 minutes ]
    Assessment of the value of the pain feeling measured by visual analogic scale


Secondary Outcome Measures :
  1. Delay in treatment efficacy [ Time Frame: up to 45 minutes ]
    Delay in treatment efficacy measured by a reduction of pain (1 point) assessed by visual analogic scale from the administration of the treatement.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   4 Years to 15 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient aged between 4 years old and 15,3 years old
  • Acute pain in traumatic context with a suspicion of fracture for patient <7years old : feeling Pain >6/10 defined with a face analogue scale and a visual analogic scale (the difference between the scales is not <10 points)
  • For patients >7 years old : feeling pain >6 points and defined thanks to a visual analogic scale
  • Informed consent form signed by parents
  • Beneficiary of an european health protection

Exclusion Criteria:

  • Antalgic ( II or III) within 4 hours before the inclusion
  • Allergic or non-indication of fentanyl
  • Allergic or contraindication of morphine sulfate
  • Pre existing peripheral intravenous catheter
  • Traumatic brain injury
  • Nasal traumatic

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03063359


Contacts
Layout table for location contacts
Contact: Gael GG GUYON, MD +334 67 33 22 86 g-guyon@chu-montpellier.fr
Contact: Maelis RAITIERE, Intern +334 67 33 22 86 m-raitiere@chu-montpellier.fr

Locations
Layout table for location information
France
University hospital of Montpellier Recruiting
Montpellier, France, 34295
Contact: Gaël GG GUYON, MD       g-guyon@chu-montpellier.fr   
Sponsors and Collaborators
University Hospital, Montpellier
Investigators
Layout table for investigator information
Principal Investigator: Gaël GG GUYON, MD Montpellier University Hospital

Layout table for additonal information
Responsible Party: University Hospital, Montpellier
ClinicalTrials.gov Identifier: NCT03063359     History of Changes
Other Study ID Numbers: 9732
First Posted: February 24, 2017    Key Record Dates
Last Update Posted: January 7, 2019
Last Verified: January 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University Hospital, Montpellier:
traumatic pain
children
fentanyl
intranasal use

Additional relevant MeSH terms:
Layout table for MeSH terms
Acute Pain
Pain
Neurologic Manifestations
Signs and Symptoms
Morphine
Fentanyl
Analgesics, Opioid
Narcotics
Central Nervous System Depressants
Physiological Effects of Drugs
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Adjuvants, Anesthesia
Anesthetics, Intravenous
Anesthetics, General
Anesthetics